Endava is trading 5.6% higher at $1.89, with no confirmed catalyst identified for the live move.
- Price context shows a rebound after the 8.48% rise on September 30; no October 1 company announcement was found.
- Recent coverage focused on the September 21 interim CFO appointment and accounting investigation; this is prior context, not a confirmed reason for this morning’s gain.
- Supplied major indices are modestly higher, but none moved more than 0.5%; broad-market causation is unconfirmed.